Local brain retention for better brain cancer drugs
Description
Glioblastoma is one of the most common primary brain neoplasms with very limited options for treatments and a low survival rate. For the last 40 years, no significant progress has been made for the therapy of this malignancy. The project aims at the further establishment of a technology and the development of drug candidates for the treatment of patients diagnosed with glioblastoma.
Key Data
Projectlead
Deputy Projectlead
Project team
Dominique Greuter, Jon Grolimund
Project partners
InCephalo AG; Universität Basel; Universität Zürich
Project status
ongoing, started 03/2024
Institute/Centre
Institute of Chemistry and Biotechnology (ICBT)
Funding partner
Innosuisse - Innovationsprojekt